Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up

Chemotherapy in light chain amyloidosis aims to normalize the involved free light chain in serum, which leads to an improvement, or at least stabilization of organ function in most responding patients. We performed a prospective single center phase 2 trial with 50 untreated patients not eligible for...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hegenbart, Ute (VerfasserIn) , Bochtler, Tilmann (VerfasserIn) , Benner, Axel (VerfasserIn) , Kimmich, Christoph (VerfasserIn) , Kristen, Arnt (VerfasserIn) , Beimler, Jörg (VerfasserIn) , Hund, Ernst (VerfasserIn) , Zorn, Markus (VerfasserIn) , Freiberger, Anja (VerfasserIn) , Peters-Gawlik, Marianne (VerfasserIn) , Goldschmidt, Hartmut (VerfasserIn) , Hose, Dirk (VerfasserIn) , Jauch, Anna (VerfasserIn) , Ho, Anthony Dick (VerfasserIn) , Schönland, Stefan (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2017
In: Haematologica
Year: 2017, Jahrgang: 102, Heft: 8, Pages: 1424-1431
ISSN:1592-8721
DOI:10.3324/haematol.2016.163246
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.3324/haematol.2016.163246
Verlag, Volltext: http://www.haematologica.org/content/102/8/1424
Volltext
Verfasserangaben:Ute Hegenbart, Tilmann Bochtler, Axel Benner, Natalia Becker, Christoph Kimmich, Arnt V. Kristen, Jörg Beimler, Ernst Hund, Markus Zorn, Anja Freiberger, Marianne Gawlik, Hartmut Goldschmidt, Dirk Hose, Anna Jauch, Anthony D. Ho, Stefan O. Schönland

MARC

LEADER 00000caa a2200000 c 4500
001 1582261288
003 DE-627
005 20230427193157.0
007 cr uuu---uuuuu
008 181024s2017 xx |||||o 00| ||eng c
024 7 |a 10.3324/haematol.2016.163246  |2 doi 
035 |a (DE-627)1582261288 
035 |a (DE-576)512261288 
035 |a (DE-599)BSZ512261288 
035 |a (OCoLC)1341021776 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hegenbart, Ute  |e VerfasserIn  |0 (DE-588)1028373708  |0 (DE-627)73062157X  |0 (DE-576)35901903X  |4 aut 
245 1 0 |a Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis  |b results of a prospective phase 2 study with long-term follow up  |c Ute Hegenbart, Tilmann Bochtler, Axel Benner, Natalia Becker, Christoph Kimmich, Arnt V. Kristen, Jörg Beimler, Ernst Hund, Markus Zorn, Anja Freiberger, Marianne Gawlik, Hartmut Goldschmidt, Dirk Hose, Anna Jauch, Anthony D. Ho, Stefan O. Schönland 
264 1 |c 2017 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 24.10.2018 
520 |a Chemotherapy in light chain amyloidosis aims to normalize the involved free light chain in serum, which leads to an improvement, or at least stabilization of organ function in most responding patients. We performed a prospective single center phase 2 trial with 50 untreated patients not eligible for high-dose treatment. The treatment schedule comprised 6 cycles of oral lenalidomide, melphalan and dexamethasone every 4 weeks. After 6 months, complete remission was achieved in 9 patients (18%), very good partial remission in 16 (32%) and partial response in 9 (18%). Overall, organ response was observed in 24 patients (48%). Hematologic and cardiac toxicities were predominant adverse events. Mortality at 3 months was low at 4% (n=2) despite the inclusion of 36% of patients (n=18) with cardiac stage Mayo 3. After a median follow-up of 50 months, median overall and event-free survival were 67.5 months and 25.1 months, respectively. We conclude that the treatment of lenalidomide, melphalan and dexamethasone is very effective in achieving a hematologic remission, organ response and, consecutively, a long survival in transplant ineligible patients with light chain amyloidosis. However, as toxicity and tolerability are the major problems of a 3-drug regimen, a strict surveillance program is necessary and sufficient to avoid severe toxicities. clinicaltrials.gov Identifier: 00883623 (Eudract2008-001405-41). 
700 1 |a Bochtler, Tilmann  |d 1975-  |e VerfasserIn  |0 (DE-588)128398957  |0 (DE-627)372639925  |0 (DE-576)187323909  |4 aut 
700 1 |a Benner, Axel  |d 1959-  |e VerfasserIn  |0 (DE-588)106584686X  |0 (DE-627)81687221X  |0 (DE-576)425536602  |4 aut 
700 1 |a Kimmich, Christoph  |e VerfasserIn  |0 (DE-588)1075478413  |0 (DE-627)833305042  |0 (DE-576)443499632  |4 aut 
700 1 |a Kristen, Arnt  |d 1974-  |e VerfasserIn  |0 (DE-588)123480965  |0 (DE-627)706314530  |0 (DE-576)293726876  |4 aut 
700 1 |a Beimler, Jörg  |d 1968-  |e VerfasserIn  |0 (DE-588)115360417  |0 (DE-627)691258740  |0 (DE-576)289834899  |4 aut 
700 1 |a Hund, Ernst  |e VerfasserIn  |0 (DE-588)17352799X  |0 (DE-627)698439953  |0 (DE-576)134372603  |4 aut 
700 1 |a Zorn, Markus  |d 1964-  |e VerfasserIn  |0 (DE-588)1033873721  |0 (DE-627)745111483  |0 (DE-576)381543137  |4 aut 
700 1 |a Freiberger, Anja  |e VerfasserIn  |0 (DE-588)1031171371  |0 (DE-627)735780587  |0 (DE-576)378581775  |4 aut 
700 1 |a Peters-Gawlik, Marianne  |e VerfasserIn  |0 (DE-588)120087189  |0 (DE-627)69636767X  |0 (DE-576)292034369  |4 aut 
700 1 |a Goldschmidt, Hartmut  |d 1956-  |e VerfasserIn  |0 (DE-588)102258023X  |0 (DE-627)717003809  |0 (DE-576)365637386  |4 aut 
700 1 |a Hose, Dirk  |d 1969-  |e VerfasserIn  |0 (DE-588)139824995  |0 (DE-627)613790308  |0 (DE-576)313431698  |4 aut 
700 1 |a Jauch, Anna  |d 1959-  |e VerfasserIn  |0 (DE-588)1025525140  |0 (DE-627)722525362  |0 (DE-576)168357496  |4 aut 
700 1 |a Ho, Anthony Dick  |d 1948-  |e VerfasserIn  |0 (DE-588)108692477  |0 (DE-627)504904205  |0 (DE-576)19010466X  |4 aut 
700 1 |a Schönland, Stefan  |d 1969-  |e VerfasserIn  |0 (DE-588)122405226  |0 (DE-627)705896137  |0 (DE-576)293255792  |4 aut 
773 0 8 |i Enthalten in  |t Haematologica  |d Pavia : Ferrata Storti Foundation, 2014  |g 102(2017), 8, Seite 1424-1431  |h Online-Ressource  |w (DE-627)814204899  |w (DE-600)2805244-4  |w (DE-576)424051125  |x 1592-8721  |7 nnas  |a Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis results of a prospective phase 2 study with long-term follow up 
773 1 8 |g volume:102  |g year:2017  |g number:8  |g pages:1424-1431  |g extent:8  |a Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis results of a prospective phase 2 study with long-term follow up 
856 4 0 |u http://dx.doi.org/10.3324/haematol.2016.163246  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.haematologica.org/content/102/8/1424  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20181024 
993 |a Article 
994 |a 2017 
998 |g 106584686X  |a Benner, Axel  |m 106584686X:Benner, Axel  |d 50000  |e 50000PB106584686X  |k 0/50000/  |p 3 
998 |g 122405226  |a Schönland, Stefan  |m 122405226:Schönland, Stefan  |d 910000  |d 910100  |e 910000PS122405226  |e 910100PS122405226  |k 0/910000/  |k 1/910000/910100/  |p 16  |y j 
998 |g 108692477  |a Ho, Anthony Dick  |m 108692477:Ho, Anthony Dick  |d 910000  |d 910100  |e 910000PH108692477  |e 910100PH108692477  |k 0/910000/  |k 1/910000/910100/  |p 15 
998 |g 1025525140  |a Jauch, Anna  |m 1025525140:Jauch, Anna  |d 910000  |d 911500  |e 910000PJ1025525140  |e 911500PJ1025525140  |k 0/910000/  |k 1/910000/911500/  |p 14 
998 |g 139824995  |a Hose, Dirk  |m 139824995:Hose, Dirk  |d 910000  |d 910100  |d 50000  |e 910000PH139824995  |e 910100PH139824995  |e 50000PH139824995  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 13 
998 |g 102258023X  |a Goldschmidt, Hartmut  |m 102258023X:Goldschmidt, Hartmut  |d 910000  |d 910100  |e 910000PG102258023X  |e 910100PG102258023X  |k 0/910000/  |k 1/910000/910100/  |p 12 
998 |g 120087189  |a Peters-Gawlik, Marianne  |m 120087189:Peters-Gawlik, Marianne  |d 910000  |d 910100  |e 910000PP120087189  |e 910100PP120087189  |k 0/910000/  |k 1/910000/910100/  |p 11 
998 |g 1031171371  |a Freiberger, Anja  |m 1031171371:Freiberger, Anja  |d 910000  |d 913000  |e 910000PF1031171371  |e 913000PF1031171371  |k 0/910000/  |k 1/910000/913000/  |p 10 
998 |g 1033873721  |a Zorn, Markus  |m 1033873721:Zorn, Markus  |d 910000  |d 910100  |e 910000PZ1033873721  |e 910100PZ1033873721  |k 0/910000/  |k 1/910000/910100/  |p 9 
998 |g 17352799X  |a Hund, Ernst  |m 17352799X:Hund, Ernst  |d 50000  |e 50000PH17352799X  |k 0/50000/  |p 8 
998 |g 115360417  |a Beimler, Jörg  |m 115360417:Beimler, Jörg  |d 910000  |d 910100  |e 910000PB115360417  |e 910100PB115360417  |k 0/910000/  |k 1/910000/910100/  |p 7 
998 |g 123480965  |a Kristen, Arnt  |m 123480965:Kristen, Arnt  |d 910000  |d 910100  |e 910000PK123480965  |e 910100PK123480965  |k 0/910000/  |k 1/910000/910100/  |p 6 
998 |g 1075478413  |a Kimmich, Christoph  |m 1075478413:Kimmich, Christoph  |d 910000  |d 910100  |e 910000PK1075478413  |e 910100PK1075478413  |k 0/910000/  |k 1/910000/910100/  |p 5 
998 |g 128398957  |a Bochtler, Tilmann  |m 128398957:Bochtler, Tilmann  |d 910000  |d 910100  |e 910000PB128398957  |e 910100PB128398957  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1028373708  |a Hegenbart, Ute  |m 1028373708:Hegenbart, Ute  |d 910000  |d 910100  |e 910000PH1028373708  |e 910100PH1028373708  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1582261288  |e 3029641759 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"recId":"814204899","disp":"Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis results of a prospective phase 2 study with long-term follow upHaematologica","titleAlt":[{"title":"journal of the European Hematology Association"}],"language":["eng"],"pubHistory":["99.2014 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"dateIssuedKey":"2014","publisherPlace":"Pavia","publisher":"Ferrata Storti Foundation","dateIssuedDisp":"2014-"}],"title":[{"title":"Haematologica","title_sort":"Haematologica","subtitle":"journal of the European Hematology Association : journal of the Ferrata Storti Foundation"}],"id":{"zdb":["2805244-4"],"issn":["1592-8721"],"eki":["814204899"]},"part":{"text":"102(2017), 8, Seite 1424-1431","volume":"102","pages":"1424-1431","year":"2017","issue":"8","extent":"8"},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 27.05.2022"]}],"note":["Gesehen am 24.10.2018"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"doi":["10.3324/haematol.2016.163246"],"eki":["1582261288"]},"physDesc":[{"extent":"8 S."}],"language":["eng"],"title":[{"subtitle":"results of a prospective phase 2 study with long-term follow up","title_sort":"Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis","title":"Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis"}],"recId":"1582261288","origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"2017"}],"name":{"displayForm":["Ute Hegenbart, Tilmann Bochtler, Axel Benner, Natalia Becker, Christoph Kimmich, Arnt V. Kristen, Jörg Beimler, Ernst Hund, Markus Zorn, Anja Freiberger, Marianne Gawlik, Hartmut Goldschmidt, Dirk Hose, Anna Jauch, Anthony D. Ho, Stefan O. Schönland"]},"person":[{"display":"Hegenbart, Ute","given":"Ute","family":"Hegenbart","role":"aut"},{"family":"Bochtler","given":"Tilmann","display":"Bochtler, Tilmann","role":"aut"},{"display":"Benner, Axel","given":"Axel","family":"Benner","role":"aut"},{"display":"Kimmich, Christoph","given":"Christoph","family":"Kimmich","role":"aut"},{"role":"aut","given":"Arnt","display":"Kristen, Arnt","family":"Kristen"},{"given":"Jörg","display":"Beimler, Jörg","family":"Beimler","role":"aut"},{"role":"aut","family":"Hund","display":"Hund, Ernst","given":"Ernst"},{"family":"Zorn","given":"Markus","display":"Zorn, Markus","role":"aut"},{"role":"aut","family":"Freiberger","display":"Freiberger, Anja","given":"Anja"},{"display":"Peters-Gawlik, Marianne","given":"Marianne","family":"Peters-Gawlik","role":"aut"},{"role":"aut","family":"Goldschmidt","given":"Hartmut","display":"Goldschmidt, Hartmut"},{"given":"Dirk","display":"Hose, Dirk","family":"Hose","role":"aut"},{"family":"Jauch","display":"Jauch, Anna","given":"Anna","role":"aut"},{"display":"Ho, Anthony Dick","given":"Anthony Dick","family":"Ho","role":"aut"},{"role":"aut","display":"Schönland, Stefan","given":"Stefan","family":"Schönland"}]} 
SRT |a HEGENBARTULENALIDOMI2017